MAI Capital Management trimmed its holdings in Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Rating) by 14.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,720,676 shares of the company’s stock after selling 298,488 shares during the quarter. MAI Capital Management owned 2.87% of Trevi […]